Drug intelligence / Profile preview

mifepristone + fluvastatin

Development stage
Unknown
Lead developer
Roussel
Modality
Small Molecules
Administration
Oral
01

Overview

Mifepristone + fluvastatin is a combination of two small molecule drugs, each with distinct mechanisms and indications. **Mifepristone** is a synthetic steroid that acts as an antagonist at both the progesterone receptor and the glucocorticoid receptor. It is primarily used for medical termination of intrauterine pregnancy (in combination with misoprostol) by blocking progesterone, which is necessary to maintain pregnancy. It also blocks cortisol action at the glucocorticoid receptor, making it useful in controlling hyperglycemia secondary to hypercortisolism in Cushing's syndrome patients who have failed or are not candidates for surgery[1][2][3][4][5][6]. **Fluvastatin** is a fully synthetic statin that inhibits HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis. By lowering plasma cholesterol levels, it reduces cardiovascular risk including myocardial infarction and stroke[8]. There are no known approved or investigational uses for this specific drug combination; each agent retains its individual primary indications.

Other names
MifegymisoRU486RU-486RU 486
02

Targets

HMGCR (3-hydroxy-3-methylglutaryl-coenzyme A reductase)PR (Progesterone receptor)GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on mifepristone + fluvastatin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on mifepristone + fluvastatin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call